M. Froscio

发表

Expression of Drosophila Ca2+ permeable transient receptor potential-like channel protein in a prostate cancer cell line decreases cell survival

M. Brown, W. Tilley, G. Barritt, 2003, Cancer Gene Therapy.

Inhibition of epidermal growth factor binding to HeLa cells by auranofin.

M. Froscio, N. Hurst, A. W. Murray, 1987, Biochemical pharmacology.

Inhibition of protein kinase C activity by the antirheumatic drug auranofin.

M. Froscio, N. Hurst, A. W. Murray, 1989, Biochemical pharmacology.

Croton oil- and benzo(a)pyrene-induced changes in cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate phosphodiesterase activities in mouse epidermis.

M. Froscio, A. Verma, A. W. Murray, 1976, Cancer research.

Dissociation of rabbit muscle cyclic AMP‐dependent protein kinase into catalytic and regulatory subunits by p‐chloromercuribenzoate and methylmercuric chloride

M. Froscio, A. W. Murray, A. Rogers, 1974, FEBS letters.

Kinases from Mouse Epidermis1

M. Froscio, A. W. Murray, 1977 .

Effect of polyamines on cyclic AMP-dependent and independent protein kinases from mouse epidermis.

M. Froscio, A. W. Murray, A. Rogers, 1976, Biochemical and biophysical research communications.

Effects of cholera toxin on ornithine decarboxylase activity in mouse skin.

M. Froscio, A. W. Murray, V. Solanki, 1980, The Journal of investigative dermatology.

Multiple protein kinases from human lymphocytes. Identification enzymes phosphorylating exogenous histon and casein.

B. Kemp, M. Froscio, A. W. Murray, 1975, The Biochemical journal.

Novel variants of voltage-operated calcium channel alpha 1-subunit transcripts in a rat liver-derived cell line: deletion in the IVS4 voltage sensing region.

G. Barritt, H. Brereton, M. Froscio, 1997, Cell calcium.

Cyclic adenosine 3':5'-monophosphate and microtubule function: specific interaction of the phosphorylated protein subunits with a soluble brain component.

M. Froscio, A. W. Murray, 1971, Biochemical and biophysical research communications.

Calmodulin inhibitors modify cell surface changes triggered by a tumor promoter.

G. Guy, M. Froscio, A. W. Murray, 1981, Biochemical and biophysical research communications.

Resistance of A-431 epidermoid carcinoma cells to early membrane changes induced by tumour promoters.

G. Guy, M. Froscio, S. Pappalardo, 1982, Carcinogenesis.

Enhancement of protein kinase C-mediated EGF receptor phosphorylation by auranofin.

M. Froscio, N. Hurst, A. W. Murray, 1988, Scandinavian journal of rheumatology.

Auranofin enhances phosphorylation of putative substrates of protein kinase C in human platelets.

M. Froscio, N. Hurst, A. W. Murray, 1988, Biochemical pharmacology.

Induction of ornithine decarboxylase activity in epidermis by a tumor promoter: decreased response in mice maintained on a vitamin B6-deficient diet.

M. Froscio, A. W. Murray, 1977, Biochemical and biophysical research communications.

Effect of tumor promoters on the activity of cyclic adenosine 3':5'-monophosphate-dependent and -independent protein kinases from mouse epidermis.

M. Froscio, A. W. Murray, 1977, Cancer Research.

Histone phosphatase and cyclic nucleotide-stimulated protein kinase from human lymphocytes.

B. Kemp, M. Froscio, A. W. Murray, 1972, The Biochemical journal.

Localization of adenosine o',5'-monophosphate in mouse epidermis by immunofluorescence.

M. Froscio, A. Verma, A. W. Murray, 1976, The Journal of investigative dermatology.